(Q39544948)

12 September 2017

title

Efficacy of praziquantel against Schistosoma mansoni with particular consideration for intensity of infection (English)

1 reference

12 September 2017

0 references

1 reference

5

Tanner M

1 reference

12 September 2017

2

N'Goran EK

1 reference

12 September 2017

Utzinger J

1

1 reference

12 September 2017

N'Dri A

series ordinal

3

1 reference

12 September 2017

Lengeler C

series ordinal

4

1 reference

12 September 2017

publication date

1 November 2000

1 reference

Tropical Medicine and International Health

12 September 2017

published in

1 reference

12 September 2017

volume

5

1 reference

12 September 2017

issue

11

1 reference

12 September 2017

page(s)

771-778

1 reference

Implications of faecal egg count variation when using the Kato-Katz method to assess Schistosoma mansoni infections

12 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Praziquantel side effects and efficacy related to Schistosoma mansoni egg loads and morbidity in primary school children in north-east Ethiopia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

The epidemiology of a recent focus of mixed Schistosoma haematobium and Schistosoma mansoni infections around the 'Lac de Guiers' in the Senegal River Basin, Senegal

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Underestimation of Schistosoma mansoni prevalences.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

A model for variations in single and repeated egg counts in schistosoma mansoni infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Is Schistosomicidal Chemotherapy Sub-curative? Implications for Drug Resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Efficacy of treatment of murineSchistosoma mansoniinfections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Schistosome resistance to praziquantel: Fact or artifact?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Field trials of praziquantel and oxamniquine for the treatment of schistosomiasis mansoni in Burundi.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Schistosomiasis vaccines: a devils' advocate view

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Praziquantel--its use, cost and possible development of resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

An international initiative on praziquantel use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Schistosoma mansoni: Reduced efficacy of chemotherapy in infected T-cell-deprived mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Schistosoma mansoni: chemotherapy of infections of different ages

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Oxamniquine cures Schistosoma mansoni infection in a focus in which cure rates with praziquantel are unusually low.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

The relationship between morbidity and intensity of Schistosoma mansoni infection in a rural Zambian community

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Schistosoma mansoni, intestinal parasites and perceived morbidity indicators in schoolchildren in a rural endemic area of western Côte d'Ivoire

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

Effects of praziquantel on different developmental stages of Schistosoma mansoni in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-3156.2000.00646.X

10.1046/J.1365-3156.2000.00646.X

21 January 2018

Identifiers

DOI

1 reference

release_v4dunpgllze7vccfefh76squtq

12 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/v4dunpgllze7vccfefh76squtq

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference